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Here, we present the genome sequence, with analysis, of a poxvirus infecting Nile crocodiles (Crocodylus
niloticus) (crocodilepox virus; CRV). The genome is 190,054 bp (62% GC) and predicted to contain 173 genes
encoding proteins of 53 to 1,941 amino acids. The central genomic region contains genes conserved and
generally colinear with those of other chordopoxviruses (ChPVs). CRV is distinct, as the terminal 33-kbp (left)
and 13-kbp (right) genomic regions are largely CRV specific, containing 48 unique genes which lack similarity
to other poxvirus genes. Notably, CRV also contains 14 unique genes which disrupt ChPV gene colinearity
within the central genomic region, including 7 genes encoding GyrB-like ATPase domains similar to those in
cellular type IIA DNA topoisomerases, suggestive of novel ATP-dependent functions. The presence of 10 CRV
proteins with similarity to components of cellular multisubunit E3 ubiquitin-protein ligase complexes, includ-
ing 9 proteins containing F-box motifs and F-box-associated regions and a homologue of cellular anaphase-
promoting complex subunit 11 (Apc11), suggests that modification of host ubiquitination pathways may be
significant for CRV-host cell interaction. CRV encodes a novel complement of proteins potentially involved in
DNA replication, including a NAD-dependent DNA ligase and a protein with similarity to both vaccinia virus
F16L and prokaryotic serine site-specific resolvase-invertases. CRV lacks genes encoding proteins for nucle-
otide metabolism. CRV shares notable genomic similarities with molluscum contagiosum virus, including
genes found only in these two viruses. Phylogenetic analysis indicates that CRV is quite distinct from other
ChPVs, representing a new genus within the subfamily Chordopoxvirinae, and it lacks recognizable homologues
of most ChPV genes involved in virulence and host range, including those involving interferon response,
intracellular signaling, and host immune response modulation. These data reveal the unique nature of CRV
and suggest mechanisms of virus-reptile host interaction.
Crocodile poxviruses (CRV) and caiman poxviruses are un-
characterized and unclassified members of the subfamily Chor-
dopoxvirinae in the family Poxviridae that infect host species of
the order Crocodylia worldwide (55, 56, 59, 84, 88, 90, 97).
Similarly, uncharacterized poxviruses infecting other reptiles,
including Hermann’s tortoise, wild flap-necked chameleon,
and lizards, have been described (60, 87, 117). Morphologi-
cally, CRV and caiman poxvirus virions are brick shaped with
rounded corners and have particle dimensions and a dumbbell-
shaped central core with lateral bodies similar to orthopoxvirus
virions; however, they also exhibit a regular, crisscross surface
structure pattern characteristic of parapoxvirus virions (42, 59,
88, 90, 97).
CRV and caiman poxviruses are significant pathogens which
cause economic losses on crocodile farms in Southeast Asia,
Australia, and southern Africa and on caiman farms in South
America, largely by affecting hatchlings and smaller yearlings
(55, 56, 59, 90). Poxvirus infection reported by a Brazilian farm
affected 15% of 5- to 9-month-old Brazilian caimans, while
adults remained asymptomatic (97). Poxvirus infections have
been associated with 3.4% of all skin lesions in Australian
farmed crocodiles (Crocodylus porosus and Crocodylus
johnstoni) (16). In a CRV outbreak of 9-month-old Nile croc-
odiles (Crocodylus niloticus), 40% presented with clinical dis-
ease (52). On a Zambian farm of 4,000 hatchling to 5-year-old
animals, 300 yearlings were affected and exhibited nodular skin
lesions and complications resulting in 27% mortality (88).
CRV infections in Nile crocodiles currently occur on farms in
Zimbabwe (D. Wallace, personal communication). Although
infections with CRV have not yet been reported in the wild, the
prevalence of these viruses in diverse crocodilian populations
worldwide and their ability to cause significant disease suggest
that crocodilians are natural hosts.
CRV causes a disease that varies from a nonfatal dermatitis
with complete recovery to more severe disease characterized
by ophthalmia, rhinitis resulting in asphyxia, and debilitating
illness with stunting and high mortality (52, 56, 88). In one
CRV disease outbreak (52), yellow or brownish mucocutane-
ous lesions that varied from flat spots of 2 to 3 mm in diameter
to nodules of 8 mm, and occasionally shallow ulcers, were
common on the sides of the mouth, eyelids, nostrils, ventral
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aspects of the neck, sides of the body, belly, and limbs and were
less common in the oral cavity and on other external parts of
the body. Histopathologically, skin lesions exhibited large focal
areas of severe hyperkeratosis and parakeratosis and cells con-
taining intracytoplasmic inclusions.
Although complete genomic sequences have been deter-
mined for representative, and often multiple, viruses from clas-
sified chordopoxvirus (ChPV) genera infecting mammalian or
avian hosts (Capripoxvirus [124, 125], Leporipoxvirus [17, 128],
Molluscipoxvirus [106], Orthopoxvirus [5, 7, 24, 44, 49, 76, 108,
109], Parapoxvirus [30], Suipoxvirus [4], Yatapoxvirus [14, 68],
and Avipoxvirus [3, 123]), the CRV genome has not been char-
acterized. Reptiles, considered to be the most immediate an-
cestor of birds and mammals, are poikilothermic animals with
immune systems that remain relatively unstudied (13, 32).
Analysis of the CRV genome may reveal genes that suggest
novel mechanisms of poxvirus host range and virus-reptile host
interaction. Here, we describe the complete genome sequence,
with analysis, of CRV, identifying both its divergent nature
relative to characterized ChPVs and novel genes likely affect-
ing aspects of CRV replication and virus-host interactions.
MATERIALS AND METHODS
Virus isolation and purification. Lesion material was obtained from a
6-month-old Nile crocodile (Crocodylus niloticus) during a disease outbreak on
the Ume crocodile farm at Lake Kariba in Zimbabwe. The animal presented with
generalized skin lesions (5 mm in diameter and 1 to 2 mm high) on the belly and
sides of the tail. The lesion material was ground with mortar and pestle in
McIlvains’s hypotonic buffer and clarified by low-speed centrifugation (450  g
for 5 min) in 1% Triton X-100 and 2.6 l -mercaptoethanol/ml. Semipurified
virus was obtained by centrifugation (19,000  g, 60 min) through 36% and 20%
sucrose cushions.
DNA isolation, cloning, and sequencing. Semipurified virions were disrupted
with 1% sodium dodecyl sulfate and 100 g/ml proteinase K as described by
others (77), and DNA was extracted and precipitated using standard protocols
(102). Random DNA fragments were obtained by incomplete enzymatic diges-
tion with AciI and TaqI endonucleases (New England BioLabs, Beverly, MA),
and DNA fragments larger than 1.0 kbp were cloned and used in dideoxy
sequencing reactions as previously described (3). Reaction products were re-
solved by using an ABI PRISM 3730xl automated DNA sequencer (Applied
Biosystems, Foster City, CA). Sequence data were assembled with the Phrap and
CAP3 software programs (http://www.phrap.org) (54), and sequence gaps were
closed as described previously (3). Final DNA consensus sequences represented,
on average, 10-fold redundancy at each base position, with a Consed estimated
error rate of less than 0.01 error per 10 kbp (45).
Genome analysis. Genome DNA composition, structure, repeats, and restric-
tion enzyme patterns were analyzed as previously described (2) using the GCG
v.10 software package and EMBOSS programs (31, 99). The concatemer reso-
lution motif was identified using alignments of known poxvirus resolution motifs
(80) and predicted secondary structure (78) using the computer programs
CMBUILD and CMSEARCH (35). Briefly, known concatemer resolution motifs
(80) were used to conduct a FASTA (89) search against the GenBank database,
and all identified motifs were aligned with the program Pileup (31) to obtain a
consensus. A secondary stem loop structure for the consensus was predicted
using the program FoldRNA (31). A hidden Markov model was constructed
from the alignment and was used to search a complete viral database that
included CRV genomic sequences using HMMSEARCH and CMSEARCH
(34). Once CRV concatemer sequences and score distribution values were ob-
tained, a covariance model from predicted secondary structures of multiple
alignment, CRV, and consensus sequences was built (35). Only terminally lo-
cated concatemer resolution sequence-like motifs were identified for other pox-
viruses, indicating the specificity of the prediction.
Open reading frames (ORFs) longer than 30 codons were evaluated for coding
potential as previously described (3) and by using Framefinder (http://www.ebi
.ac.uk/guy/estate/). ORFs 30 to 60 codons in length with coding potential and
408 ORFs greater than 60 codons were subjected to similarity searches as
previously described, with additional searches against UniGene, Pfam,
TIGRFAMs, and SMART databases (2, 3, 39). Here, 173 ORFs were annotated
as potential genes and numbered from left to right. Given the predicted nature
of all CRV genes and gene products, ORF names were used throughout the text
to indicate both the predicted gene and its putative protein product. Multiple
genomic and protein alignments were done using Dialign (81), Dialign-T (118),
Clustal (121), MUSCLE (36), and/or Kalign (67) programs. Phylogenetic anal-
ysis was performed using PHYLO_WIN, TREE-PUZZLE, IQPNNI, PHYLIP,
PHYML, and MRBAYES software packages, and ProtTest was used to select
evolutionary models (1, 38, 40, 50, 57, 104, 126). Additional analyses were
conducted for alignments in which poorly aligned regions were removed with
Gblocks (21). Supertree analysis of neighbor-joining, maximum parsimony, and
maximum likelihood trees from individually aligned protein homologues was
performed using Puzzling (http://bioinf.may.ie/software/puzzling/index.html). F-box
motif searches were done with hidden Markov models using the program HMMER
(34) and publicly available matrixes (SCOP v1.69 [46] and Pfam PF00646).
Nucleotide sequence accession number. The CRV genome has been deposited
in GenBank under accession number DQ356948.
RESULTS AND DISCUSSION
Organization of the CRV genome. The genome of Nile croc-
odile poxvirus (CRV) is 190,054 bp and contains an overall
nucleotide composition of 62% CG. Notably, an island of
lower GC content (50% over 5,864 bp) encoding a novel
gene family of unknown function (CRV033, CRV034, and
CRV035) is located between nucleotide positions 27796 and
33659. As terminal hairpin loops were not sequenced, the
left-most nucleotide of the assembled genome was arbitrarily
designated base 1. A putative poxvirus concatemer resolution
motif was identified only at positions 50 to 68 from each ter-
minus, suggesting that the assembled sequence contains all but
the most terminal 50 to 100 bp of the CRV genome (Fig. 1).
The CRV genome contains a large unique coding region
bounded by two identical inverted terminal repeat (ITR) re-
gions of 1,754 bp. ITRs contain three 113-bp tandem repeats
that share approximately 92% nucleotide identity with each
other and are located between positions 719 and 1057 within
the left ITR and between positions 188998 and 189336 within
the right ITR. No additional repeats were detected in terminal
genomic regions.
One hundred-seventy three ORFs were annotated here as
potential genes, encoding proteins of 53 to 1,941 amino acids
in length and representing a coding density of 94%. The cen-
tral genomic region (CRV036 to CRV158) contains conserved
poxvirus genes involved in basic replicative mechanisms (RNA
transcription and modification and DNA replication), in virion
structure, and in assembly of intracellular mature, intracellular
enveloped, and extracellular enveloped virions (IMV, IEV,
and EEV, respectively) (Table 1) (82). Terminal genomic re-
FIG. 1. Alignment of the putative CRV concatemer resolution se-
quence region with those of other poxviruses. Genomic positions are
indicated on the right; the putative concatemer resolution sequence is
underlined. GenBank accession numbers are as follows: rabbit fibroma
virus, AF170722; myxoma virus, AF170726; Yaba-like disease virus,
YDI293568; sheeppox virus, M28823; fowlpox virus, AJ581527; swinepox
virus, AF410153; vaccinia virus, AY243312; cowpox virus, AF482758.
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TABLE 1. CRV ORFs
ORF Position (length [aa]) a
Best matchb Predicted structure
and/or function
ORF homologue f
Accession no.c Species Scored % Id.e MOCV VACV
CRV001 396–629 (78)
CRV002 3453–1174 (760)
CRV003 4562–3576 (329)
CRV004 6189–4738 (484)
CRV005 7034–6309 (242)
CRV006 7414–7211 (68)
CRV007 7679–7479 (67)
CRV008 9316–7823 (498)
CRV009 9935–9369 (189) AF428140 Homo sapiens 99 32 F-box domain protein
CRV010 10793–9966 (276) AE003835 Drosophila melanogaster 98 38 F-box domain protein
CRV011 11511–10717 (265) BC012385 Homo sapiens 113 44 F-box domain protein
CRV012 12101–11514 (196) BC012385 Homo sapiens 98 51 F-box domain protein
CRV013 12860–12186 (225) BC012385 Homo sapiens 104 39 F-box domain protein
CRV014 13491–12904 (196) AY007380 Oryza sativa 107 40 F-box domain protein
CRV015 14185–13568 (206) AE002690 Drosophila melanogaster 118 38 F-box domain protein
CRV016 15613–14282 (444)
CRV017 16212–15703 (170)
CRV018 16815–16300 (172)
CRV019 17395–16910 (162)
CRV020 17881–17477 (135)
CRV021 19113–17800 (438) L22174 Gallid herpesvirus 2 177 38 SORF2 domain protein
CRV022 20308–19403 (302)
CRV023 21309–20395 (305)
CRV024 21975–22205 (77)
CRV025 22584–22216 (123)
CRV026 23363–22611 (251) AC114983 Oryza sativa 122 36 F-box domain protein
CRV027 24125–23382 (248)
CRV028 25327–24380 (316)
CRV029 25892–25515 (126)
CRV030 26679–25993 (229) 312 35 J-domain protein MC013L
CRV031 26857–26660 (66)
CRV032 27712–26963 (250)
CRV033 29408–27981 (476)
CRV034 31619–29556 (688)
CRV035 33591–31948 (548)
CRV036 34288–33650 (213) 407 46 MC016L F9L
CRV037 35662–34292 (457) 1122 50 Ser/Thr protein kinase MC017L F10L
CRV038 37738–35675 (688) 384 28 IEV protein MC019L F12L
CRV039 38905–37793 (371) 684 44 Palmitylated EEV
envelope lipase
MC021L F13L
CRV040 44775–39052 (1908) L22579 Variola virus 1237 30 VARV B22R-like
protein
MC035R
CRV041 50525–44904 (1874) 1179 28 VARV B22R-like
protein
MC035R
CRV042 56371–58035 (555) AY070554 Drosophila melanogaster 102 28 RING-like motif
protein
CRV043 56486–50664 (1941) 1318 32 VARV B22R-like
protein
MC035R
CRV044 58267–58025 (81)
CRV045 58348–60159 (604) AY532606 Rock bream iridovirus 114 29 RING-like motif
protein
CRV046 61179–60535 (215) AY318871 Canarypox virus 246 35 MC025L F15L
CRV047 61457–61215 (81) AY340984 Squirrel parapoxvirus 115 30 Apc11-like protein MC026L
CRV048 63339–61411 (643)
CRV049 64738–63293 (482)
CRV050 65456–64734 (241) 109 24 MC028L
CRV051 66163–65477 (229) AF426834 Staphylococcus epidermidis
Tn552
99 30 Site-specific
recombinase-like
protein
MC029L F16L
CRV052 67293–66214 (360) AY653733 Acanthamoeba polyphaga
mimivirus
126 31 NAD-dependent DNA
ligase
CRV053 67365–67715 (117) AX754989 Orf virus 144 34 DNA-binding virion
core protein
MC030R F17R
CRV054 69126–67708 (473) AF198100 Fowlpox virus 940 41 Poly(A) polymerase
large subunit
MC031L E1L
CRV055 71484–69154 (777) 338 28 E2L/O1L-like protein MC032L E2L
Continued on facing page
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TABLE 1—Continued
ORF Position (length [aa])a
Best matchb Predicted structure
and/or function
ORF homologue f
Accession no.c Species Scored % Id.e MOCV VACV
CRV056 72065–73762 (566) 1295 43 MC037R E6R
CRV057 72066–71503 (188) AY318871 Canarypox virus 567 58 RNA polymerase
subunit RP030
MC034L E4L
CRV058 73770–76151 (794) AF170726 Myxoma virus 674 48 Virion core protein MC038R E8R
CRV059 79159–76196 (988) 2554 51 DNA polymerase MC039L E9L
CRV060 79194–79484 (97) AJ581527 Fowlpox virus 281 48 IMV redox protein MC040R E10R
CRV061 79851–79468 (128) 151 33 Virion core protein MC041L E11L
CRV062 82021–79841 (727) 560 29 E2L/OIL-like protein MC042L O1L
CRV063 84329–82035 (765) 186 27 E2L/OIL-like protein MC042L O1L
CRV064 86716–84452 (755) X94355 Cowpox virus 112 23 E2L/OIL-like protein MC042L E2L
CRV065 87777–86851 (309) AY318871 Canarypox virus 856 54 DNA-binding virion
core protein
MC044L I1L
CRV066 87983–87789 (65) AY386265 Bovine papular stomatitis
virus
120 50 MC045L I2L
CRV067 88709–87990 (240) AF438165 Camelpox virus 176 28 DNA-binding
phosphoprotein
MC046L I3L
CRV068 88962–88726 (79) P18521 Fowlpox virus 152 35 IMV membrane protein MC047L I5L
CRV069 90129–88966 (388) E48563 Fowlpox virus 571 32 Telomere binding
protein
MC048L I6L
CRV070 91421–90129 (431) 1064 50 Virion core proteinase MC049L I7L
CRV071 91427–93448 (674) 1685 51 RNA helicase NPH-II MC050R I8R
CRV072 95364–93466 (633) 1322 47 Metalloprotease MC056L G1L
CRV073 95681–95364 (106) 97 37 MC057L G3L
CRV074 95692–96390 (233) 276 37 Transcriptional
elongation factor
MC058R G2R
CRV075 96686–96339 (116) AF198100 Fowlpox virus 131 24 Glutaredoxin 2 MC059L G4L
CRV076 96689–98053 (455) 546 36 Virion core protein MC060R G5R
CRV077 98034–98222 (63) AF198100 Fowlpox virus 236 68 RNA polymerase
subunit RPO7
MC061R G5.5R
CRV078 98237–98818 (194) 351 48 MC062R G6R
CRV079 99883–98852 (344) AF170726 Myxoma virus 378 31 Virion core protein MC065L G7L
CRV080 99914–100687 (258) AF170722 Rabbit fibroma virus 754 55 Late transcription
factor VLTF-1
MC067R G8R
CRV081 100703–101686 (328) P15909 Fowlpox virus 614 37 Myristylated protein MC068R G9R
CRV082 101690–102442 (251) AF198100 Fowlpox virus 727 56 Myristylated IMV
envelope protein
MC069R L1R
CRV083 102510–102776 (89) AF482758 Cowpox virus 105 36 MC070R L2R
CRV084 103047–104528 (494) P35886 Streptomyces coelicolor 136 28 GyrB-like ATPase
domain protein
CRV085 104673–106115 (481) P30182 Arabidopsis thaliana 77 24 GyrB-like ATPase
domain protein
CRV086 106180–107355 (392) AB110283 Trichophyton verrucosum 110 28 GyrB-like ATPase
domain protein
CRV087 107445–108695 (417) AB049145 Pichia guilliermondii 123 23 GyrB-like ATPase
domain protein
CRV088 108890–110134 (415) AE010515 Fusobacterium nucleatum 127 28 GyrB-like ATPase
domain protein
CRV089 110183–111709 (509) P30182 Arabidopsis thaliana 91 28 GyrB-like ATPase
domain protein
CRV090 111854–114904 (1017) CNS07EGB Encephalitozoon cuniculi 250 23 GyrB-like ATPase
domain protein
CRV091 114900–115190 (97) 60 39 MC071R
CRV092 116070–115165 (302) AY318871 Canarypox virus 612 42 MC072L L3L
CRV093 116097–116831 (245) AY318871 Canarypox virus 410 36 DNA-binding virion
core protein
MC073R L4R
CRV094 116827–117216 (130) AY386265 Bovine papular stomatitis
virus
207 40 IMV membrane protein MC074R L5R
CRV095 117182–117649 (156) 257 44 IMV membrane protein MC075R J1R
CRV096 117667–118548 (294) 820 56 Poly(A) polymerase
small subunit
MC076R J3R
CRV097 118585–119151 (189) 510 49 RNA polymerase
subunit RPO22
MC077R J4R
CRV098 119536–119141 (132) M17418 Fowlpox virus 359 45 MC078L J5L
CRV099 119586–123452 (1289) 4673 67 RNA polymerase
subunit RPO147
MC079R J6R
CRV100 123495–123719 (75) 69 31 MC081R
Continued on facing page
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TABLE 1—Continued
ORF Position (length [aa])a
Best matchb Predicted structure
and/or function
ORF homologue f
Accession no.c Species Scored % Id.e MOCV VACV
CRV101 124106–124804 (233) 547 55 IMV membrane protein MC083R H2R
CRV102 124206–123706 (167) P33064 Variola virus 357 44 Tyr/Ser protein
phosphatase
MC082L H1L
CRV103 125614–124781 (278) AY318871 Canarypox virus 241 24 IMV envelope protein MC084L H3L
CRV104 128017–125618 (800) AF380138 Monkeypox virus 1951 47 RNA-polymerase-
associated protein
MC085L H4L
CRV105 128136–128504 (123) AY386264 Orf virus 88 32 Late transcription
factor VLTF-4
MC086R H5R
CRV106 128504–129475 (324) AF198100 Fowlpox virus 881 52 DNA topoisomerase IB MC087R H6R
CRV107 129438–129863 (142) 123 34 MC088R H7R
CRV108 130203–129847 (119) 69 25 MC089L
CRV109 130219–132762 (848) 2241 56 mRNA capping enzyme
large subunit
MC090R D1R
CRV110 133117–133992 (292) 178 32 Virion core protein MC092R D3R
CRV111 133118–132765 (118) 147 42 Virion core protein MC091L D2L
CRV112 133928–134602 (225) AY386263 Orf virus 634 49 Uracil DNA glycosylase MC093R D4R
CRV113 134666–137008 (781) AY318871 Canarypox virus 2022 49 NTPase, DNA
replication
MC094R D5R
CRV114 137008–138906 (633) 2442 73 Early transcription
factor small subunit
MC095R D6R
CRV115 138896–139390 (165) 443 52 RNA polymerase
subunit RPO18
MC097R D7R
CRV116 139425–140120 (232) AY318871 Canarypox virus 429 43 MutT motif MC098R D9R
CRV117 140080–140829 (250) 239 31 MutT motif MC099R D10R
CRV118 142709–140832 (626) S42251 Fowlpox virus 1813 53 NPH-1, transcription
termination
MC100R D11L
CRV119 143578–142712 (289) 829 54 mRNA capping enzyme
small subunit
MC101L D12L
CRV120 145205–143574 (544) 1503 52 Rifampin resistance
protein
MC102L D13L
CRV121 145665–145228 (146) AY318871 Canarypox virus 306 41 Late transcription
factor VLTF-2
MC103L A1L
CRV122 146386–145712 (225) AY318871 Canarypox virus 832 68 Late transcription
factor VLTF-3
MC104L A2L
CRV123 146592–146386 (69) AF198100 Fowlpox virus 115 36 Virion redox protein MC105L A2.5L
CRV124 148623–146599 (675) 1617 49 Virion core protein P4b MC106L A3L
CRV125 148942–148673 (90) Virion core protein MC107L A4L
CRV126 148982–149455 (158) 405 54 RNA polymerase
subunit RPO19
MC108R A5R
CRV127 151081–149492 (530) 692 36 MC109L A6L
CRV128 153193–151097 (699) AF198100 Fowlpox virus 2202 58 Early transcription
factor large subunit
MC110L A7L
CRV129 153237–154112 (292) AF170726 Myxoma virus 479 39 Intermediate
transcription factor
VITF-3
MC111R A8R
CRV130 154313–154092 (74) 195 52 IMV membrane protein MC112L A9L
CRV131 157057–154334 (908) 1525 37 Virion core protein P4a MC113L A10L
CRV132 157072–158016 (315) 545 40 Nonstructural protein MC114R A11R
CRV133 158505–158086 (140) 216 41 Virion core protein MC115L A12L
CRV134 159194–158814 (127) 42 47 MC116R
CRV135 159439–159239 (67) 95 31 IMV membrane protein MC117L A13L
CRV136 159730–159443 (96) 177 41 IMV membrane protein MC118L A14L
CRV137 159909–159751 (53) 127 47 IMV membrane protein MC119L A14.5
CRV138 160193–159909 (95) AY386263 Orf virus 59 48 Virion core protein MC120L A15L
CRV139 161277–160114 (388) 823 48 Myristylated membrane
protein
MC121L A16L
CRV140 161823–161299 (175) P68592 Vaccinia virus 163 31 IMV membrane protein MC122L A17L
CRV141 161828–163204 (459) AF198100 Fowlpox virus 1140 49 DNA helicase,
transcription
elongation
MC123R A18R
CRV142 163451–163188 (88) AF198100 Fowlpox virus 123 36 MC124L A19L
CRV143 163765–165096 (444) 243 27 DNA polymerase
processivity factor
MC126R A20R
CRV144 163766–163455 (104) 226 47 IMV membrane protein MC125L A21L
CRV145 165044–165523 (160) 244 41 Holliday junction
resolvase
MC127R A22R
Continued on facing page
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gions (CRV001 to CRV035 and CRV159 to CRV173) largely
contain genes of unknown function, including one gene dupli-
cated in the ITRs and 12 genes that comprise two novel gene
families. Sixty-two CRV genes lack recognizable homologues
in other poxviruses. Of these, 33 are located in the left-termi-
nal region, 15 are located in the right-terminal region, and 14
are present in regions that disrupt colinearity within the core of
conserved ChPV genes (Table 1). Notably, a majority of the
CRV genes present in six gene families were novel, as only
seven of 29 resembled genes found in other poxviruses. Forty-
four of these unique CRV genes are completely novel, with
predicted products lacking similarity to all known proteins or
protein domains.
Notable CRV genes. (i) CRV ubiquitin ligase-related genes.
CRV encodes multiple proteins which may have functions
associated with ubiquitin ligase (E3) enzyme components of
the ubiquitin proteolytic system, a conserved system which
selectively targets proteins for degradation to affect many
critical cellular functions (51, 93). E3 enzymes function to
recruit ubiquitin conjugating (E2) enzymes to specific ubiq-
uitination substrates. The multitude of cellular E3 enzymes
identified, including both multisubunit complexes and single
subunit enzymes, reflects the array of cellular processes
controlled through the ubiquitin proteolytic system. CRV
encodes 10 proteins with features similar to components of
Skp1-Cul1-F box (SCF1) and anaphase-promoting complex/
cyclosome (APC/C) E3 ligase complexes, including 9 pro-
teins containing F-box motifs and F-box-associated regions
and 1 homologue of APC/C subunit 11 (Apc11). CRV also
encodes two novel proteins containing motifs similar to
C3HC4 RING fingers characteristic of single-subunit E3
enzymes.
Nine genes (CRV009 to CRV015, CRV026, and CRV167)
comprise the largest CRV gene family. Their predicted pro-
teins contain a 44-amino-acid F-box motif and conserved res-
idues at the amino terminus (Table 1; Fig. 2) (65). In addition,
these proteins contain an adjacent region resembling the F-
box-associated region present in a subset of eukaryotic F-box-
containing proteins (58). Seven CRV F-box proteins (CRV009
to CRV015), ranging in size from 189 to 276 amino acids, are
located in tandem in the left-terminal genomic region. How-
ever, they share only limited amino acid identity outside the
TABLE 1—Continued
ORF Position (length [aa])a
Best matchb Predicted structure
and/or function
ORF homologue f
Accession no.c Species Scored % Id.e MOCV VACV
CRV146 165531–166679 (383) 882 49 Intermediate
transcription factor
VITF-3
MC128R A23R
CRV147 166707–170153 (1149) 4399 71 RNA polymerase
subunit RPO132
MC129R A24R
CRV148 171565–170228 (446) AF198100 Fowlpox virus 137 22 IMV A type inclusion-
like protein P4c
MC133L A27L
CRV149 171985–171569 (139) 391 51 IMV membrane protein MC134L A28L
CRV150 172897–171989 (303) 541 39 RNA polymerase
subunit RPO35
MC135L A29L
CRV151 173075–172863 (71) 99 36 Virion core protein MC136L A30L
CRV152 173175–173507 (111) AF198100 Fowlpox virus 182 29 MC138R A31R
CRV153 173519–173875 (119) 74 25 MC139R
CRV154 174596–173850 (249) 622 49 ATPase, DNA
packaging
MC140L A32L
CRV155 174649–175326 (226)
CRV156 175209–175661 (151)
CRV157 175674–176054 (127)
CRV158 176306–176791 (162) AF380138 Monkeypox virus 98 23 EEV envelope protein MC143R A34R
CRV159 176835–177158 (108)
CRV160 177231–177980 (250)
CRV161 177970–178368 (133)
CRV162 178454–178741 (96)
CRV163 178795–180225 (477)
CRV164 180365–180697 (111)
CRV165 180979–181680 (234) KDEL motif
CRV166 181750–182316 (189)
CRV167 182779–183597 (273) AF176524 Mus musculus 111 51 F-box domain protein
CRV168 184231–186165 (645)
CRV169 186333–186863 (177)
CRV170 187094–187690 (199)
CRV171 187753–188211 (153)
CRV172 188256–189398 (381)
CRV173 189659–189426 (78)
a aa, amino acids.
b Best-matching protein sequence from Blast2 analysis of nonredundant protein database.
c GenBank or SwissProt database accession number.
d Blast2 score. Scores in boldface type indicate best matches to MOCV homologues, and italics indicate scores generated in searches against a MOCV database.
e % Id., percent amino acid identity in local match. Values in boldface type are matches against MOCV homologues.
f Best-matching ORF from MOCV or VACV strain Copenhagen genomes (GenBank accession numbers U60315 and M35027, respectively).
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F-box domain (26 to 32%). Notably, CRV167 lacks any simi-
larity to other family members outside the amino-terminal
F-box region.
F-box proteins are critical components of the conserved SCF
E3 complex, in which any one of a large number of inter-
changeable F-box proteins serve as substrate-specificity/recog-
nition subunits (20, 27, 91). Substrate specificity is dictated by
the bipartite structure of the F-box protein, with the conserved
F-box motif binding to Skp1 adapter protein in the core com-
plex and a divergent protein-protein interaction motif selec-
tively binding the cognate substrate to be recruited for ubiq-
uitination. Sequence diversity among the many currently
identified F-box proteins suggests that SCF-dependent prote-
olysis affects numerous substrates and cellular pathways; in-
deed, F-box proteins have roles ranging from nutrient sensing
in yeast to developmental and cell cycle pathways in plants and
animals and, recently, regulation of the inhibitor of apoptosis
protein (IAP1) in Drosophila spp. (20, 27, 105). CRV F-box
proteins may have a similar role in ubiquitination, with vari-
ability among CRV proteins conceivably resulting in multiple
target substrates affecting multiple cellular pathways.
Given the presence of F-box-like proteins in CRV, ORFs
from other ChPVs were examined for similar motifs. Notably,
a shorter (32-amino-acid), carboxyl-terminal F-box-like do-
main is present in many of the ankyrin repeat proteins encoded
by multigene families in mammalian and avian ChPVs (data
not shown) (114). Known cellular E3 substrate-receptor sub-
units contain a range of E3 core binding and substrate inter-
action motifs, including carboxyl-terminal core binding motifs
and ankyrin repeat substrate interaction motifs (10, 71, 91).
Vaccinia virus (VACV) K1L ankyrin repeat protein is able to
prevent degradation of IB-, an NF-B inhibitor normally
ubiquitinated during induction of proinflammatory responses,
implicating poxvirus-encoded ankyrin repeats in ubiquitin-me-
diated events (110). Although the functional significance of a
shorter, poxviral F-box-like domain is unclear, its presence in a
family of proteins containing a diverse array of ankyrin repeats
suggests that these ChPV proteins may encode F-box and
substrate interaction functions and provide novel substrate
specificities to endogenous E3 ligase complexes. In support of
this hypothesis, the myxoma virus ankyrin repeat protein and
virulence factor M-T5 was recently shown to contain a carboxyl-
terminal F-box-like motif, to interact with the cellular E3 ligase
subunit cul-1, to promote ubiquitination of the cul-1 substrate
p27, and to affect viral inhibition of cell-cycle arrest and cell
death (61). Interestingly, CRV lacks homologues of ChPV
ankyrin repeat proteins and also of ChPV gene family proteins
containing both BTB and kelch-like motifs, motifs known to
act as E3 core binding and substrate recognition motifs, re-
spectively, in cellular substrate receptor subunits (91). Con-
ceivably, CRV F-box-containing proteins could provide E3
complex-related host-range functions analogous to those of
ankyrin repeat and kelch-like proteins in other ChPVs.
CRV047 (81 amino acids) is homologous to molluscum con-
tagiosum virus (MOCV) MC026L, parapox virus 014, and
squirrelpox virus 026L and is comprised largely of a modified
RING finger motif similar to the RING-H2 motif of cellular
APC/C subunit 11 (Apc11) and ring box E3 subunits from
divergent species (93). The RING-H2 domain of cellular
Apc11 proteins (84 to 132 amino acids) interacts directly with
E2 enzyme to recruit it to the APC and allow ubiquitination of
protein substrates (43, 120), and it is essential for the minimum
E3 ligase activity observed for Saccharomyces cerevisiae Apc11
(69). A similar role for CRV047 in E3 ubiquitin ligase complex
formation or function, conceivably directing E3 activity to
unique cellular substrates and affecting ubiquitin-mediated
CRV-host interaction, is possible.
CRV042 and CRV045 contain carboxyl-terminal motifs sim-
ilar to C3HC4-type RING finger motifs characteristic of a
diverse array of single subunit E3 ubiquitin ligases, including
ectromelia virus p28, a host range factor whose C3HC4 motif
is required for E3 activity and viral virulence (53, 85, 92, 107).
CRV042 and CRV045 contain all C and additional non-C
residues present in C3HC4 RING motifs; however, they lack
the conserved H residue critical for binding one of two zinc
ions coordinated by the C3HC4 RING motif (data not shown)
(11). Outside the RING-like domain, CRV042 and CRV045
share similarity with each other (22% amino acid identity over
410 amino acids) but lack similarity to other C3HC4 RING
finger proteins. Although other novel RING-like motifs lack-
ing the H residue have been shown to coordinate single zinc
ions and contain intrinsic E3 activity, the function of RING-
like motifs in CRV042 and CRV045 is unclear (19).
The presence of multiple CRV genes with the potential to
affect E3 activities suggests that this is an effective mechanism
through which CRV, like other viruses, may modulate protein
degradation for the manipulation of host responses to infec-
tion. E3 ubiquitin ligases are involved in the regulation of
many aspects of innate and adaptive immune responses, in-
cluding activation of NF-B and antigen-receptor-mediated
signaling pathways, proteasome-dependent processing of anti-
genic peptides in antigen-presenting cells, activation of T lym-
phocytes, induction of T-cell tolerance, and Toll-like receptor
signaling intensity and duration, and they also affect virion
budding during certain viral infections (25, 72). F-box pathways
are also exploited by human immunodeficiency virus to rid
infected T cells of the CD4 membrane receptor, thereby re-
ducing superinfection and exposure of infected cells to im-
mune surveillance (75). Binding of herpes simplex virus 1 rep-
lication initiator protein UL9 to the E3 component neural
F-box 42-kDa protein (NFB42) leads to a significant decrease
in UL9 and is a specific interaction potentially involved in the
FIG. 2. Alignment of CRV and cellular F-box proteins. The high-
lighted, boldface, and capital letters indicate residues similar to a previ-
ously described 234 F-box consensus (65). Residues in boldface type are
present in 40% of this previously described data set, those highlighted
are present in 20 to 40%, and those in capital letters are present in greater
than 10%. Amino acid positions are indicated on the right. F-box protein
sequence names correspond to the following GenBank accession num-
bers: rat, Q7TSL3; mouse, Q9QZM8; and human, Q96EF6.
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switch of herpes simplex virus 1 from active replication to
neuronal latency (37). Human papillomavirus E6 protein re-
cruits cellular E3 for the degradation of tumor suppressor
protein p53 (103). Viral F-box proteins include those encoded
by atadeno- and nanoviruses, which have been reported to
manipulate SCF complexes (8, 12). Thus, the large number of
CRV-encoded proteins likely to affect ubiquitination suggests
that CRV has potential for manipulating the ubiquitin proteo-
lytic system through a diverse range of ubiquitin-mediated
degradation pathways. This may be of particular relevance for
virus-reptile host interactions.
(ii) GyrB-like ATPase domain gene family. CRV084, CRV085,
CRV086, CRV087, CRV088, CRV089, and CRV090 comprise
a family of genes which encode proteins sharing 26 to 42%
amino acid identity with each other and similarity to the amino-
terminal GyrB-like ATPase domain of type II DNA topo-
isomerases (topo II). CRV GyrB-like ATPase domain ORFs
are tandemly arranged in a central genomic location that dis-
rupts colinearity with other ChPVs (Table 1). Eukaryotic topo
II holoenzymes are homodimers of polypeptides that contain
an amino-terminal ATPase domain similar to that of the bac-
terial DNA gyrase subunit GyrB, a centrally located cleavage
and religation (CR) domain, and a carboxyl-terminal tail in-
volved in nuclear localization and interaction with other pro-
teins (22). The GyrB ATPase domain is an ATP binding mod-
ule that forms a fold common with several enzymes now
grouped into the GHKL family, which includes the gyrase class
of topoisomerases, heat shock protein 90 (Hsp90), histidine
kinases, and MutL DNA mismatch repair proteins, and which
likely confers a common ATP-dependent mechanism to func-
tionally distinct enzymes (33). All CRV GyrB-like ATPase
domains contain sequences similar to the topo II-like GyrB
ATPase domain, including Bergerat fold motifs I and III, sug-
gestive of an ATP binding and hydrolysis function (Fig. 3 and
data not shown) (9). Notably, only CRV090 contains se-
quences reminiscent of a CR domain, making it the longest
(1,017 amino acids) and most topo II-like member of the CRV
family. CRV090 shares, over its length, 23% amino acid iden-
tity to topo II of fungi and Paramecium bursaria chlorella virus
1. However, the CRV090 CR-like domain is divergent within
the putative metal binding Toprim (topoisomerase-primase)
region conserved in other topo II, including the PROSITE
FIG. 3. Amino acid alignment of CRV GyrB-like ATPase domain proteins and cellular topoisomerase II. Highlighted are residues identical to
those in CRV genes. Underlined are Bergerat fold motifs I (where E involves hydrolysis and N binds Mg) and III. h, hydrophobic; x, any residue;
Talaromyces, Talaromyces flavus (fungi) (GenBank accession number AB078356); Microspora, Encephalitozoon cuniculi (AL590444); Nicotiana,
Nicotiana tabacum (AY169238); Drosophila, Drosophila melanogaster (P15348). Numbers on the right indicate amino acid positions.
VOL. 80, 2006 GENOME OF CROCODILEPOX VIRUS 4985
 
topo II signature (PS00177), and it lacks a Y residue homol-
ogous to the topo II CR catalytic site (data not shown) (26). All
CRV GyrB-like ATPase domain proteins lack a recognizable
topo II-like carboxyl-terminal tail. Thus, all CRV GyrB-like
ATPase domain proteins appear deficient in domains or resi-
dues that would predict metal binding and DNA cleavage and
reunion activity of fully functional topo II. Notably, CRV also
encodes a homologue of the type IB DNA topoisomerase
conserved in other poxviruses (CRV106), likely providing sim-
ilar transcription-related functions in CRV (28). Features of
CRV GyrB ATPase domain proteins suggest that they may
have energy-dependent functions potentially involving novel
virus-host interactions.
(iii) Additional CRV gene families. CRV contains gene fam-
ilies with homologues in other ChPVs, including those similar
to variola virus (VARV) B22R and those similar to VACV
E2L and O1L. CRV040, CRV041, and CRV043 are similar to
VARV B22R, making CRV and avipoxviruses the only ChPVs
to encode multiple full-length homologues. B22R-like genes
are the largest known poxvirus genes, encoding proteins of
unknown function but predicted to contain transmembrane
domains. CRV B22R-like genes occupy genomic locations dis-
tinct from mammalian ChPV homologues (Table 1), with en-
coded proteins sharing less than 32% amino acid identity with
full-length ChPV homologues. Notably, CRV B22R-like genes
are located in a region that also contains a B22R-like gene in
avipoxviruses, viruses which contain six B22R-like genes (data
not shown). CRV055, CRV062, CRV063, and CRV064 repre-
sent a gene family characterized by similarity to two ChPV
genes of unknown function (homologues of VACV E2L and
O1L) (106). Notably, CRV028, CRV033, CRV034, and
CRV035 are members of a previously undescribed, highly vari-
able gene family whose products share only 26 to 30% amino
acid identity and lack similarity to known proteins (Table 1).
(iv) Other notable CRV genes. CRV contains four genes of
particular interest, including two (CRV052 and CRV021) that
have homologues identified thus far only for viruses infecting
nonmammalian hosts, one (CRV030) shared uniquely with
MOCV, and one (CRV051) that suggests a novel function for
homologues in other mammalian poxviruses.
CRV052 is similar to NAD-dependent DNA ligases en-
coded by mimivirus, entomopoxviruses, insect iridovirus, and
bacteria (approximately 26% amino acid identity) (Table 1).
CRV052 (360 amino acids) contains a modified NAD ligase
signature (PROSITE PS01056), including the active site motif
(KXDG, position 192 to 195) and AMP binding residue. It is,
however, considerably smaller than other viral (520 to 636
amino acids) and bacterial (approximately 630 to 840 amino
acids) ligases. CRV052 contains nucleotidyl transferase motifs
I, III, and IV, with motif IV exhibiting a D/E substitution not
predicted to affect coordination of catalytic metal ions.
CRV052 lacks, however, discernible motifs IIIa and V, includ-
ing a K residue likely important for ligation, and the zinc finger
motif present in many bacterial ligases. An additional 150
amino acids present in the amino terminus of CRV052 may
compensate for its lack of motif V. CRV052 may be a func-
tional, albeit divergent, NAD-dependent ligase similar to
those in entomopoxviruses; if so, it would be the first ChPV
NAD ligase described (73, 115). Alternatively, CRV052 may
function as a novel nucleotidyl transferase (W. Cao, personal
communication). CRV, like MOCV, parapoxviruses, and yata-
poxviruses, does not contain a homologue of VACV A50R, a
nonessential ATP-dependent DNA ligase that affects viral sen-
sitivity to genotoxic agents and viral virulence in vivo and is
present in other poxvirus genera (64).
CRV021 contains a 160-amino-acid domain similar (31 to
37% amino acid identity) to those encoded by several unre-
lated viruses infecting birds (avian poxvirus, herpesvirus, and
adenovirus isolates), vertebrate iridoviruses, and in cDNA se-
quences expressed in vertebrate species (Table 1 and data not
shown). CRV021 also contains a carboxyl-terminal domain ab-
sent in other related ORFs, suggesting that additional functional
domains are present. The CRV021-like protein (SORF2) en-
coded by Marek’s disease virus, a tumorogenic alphaherpes-
virus of domestic fowl, has been previously characterized as
similar to the FPV250 protein of fowlpox virus and is highly
similar (73% amino acid identity) to a predicted protein en-
coded in chicken cDNA and genomic sequences (data not
shown) (15). Notably, the nonessential Marek’s disease virus
SORF2 protein interacts with chicken growth hormone, a cel-
lular protein associated with resistance to Marek’s disease
(70). The presence of this CRV021-like domain in different
viral and eukaryotic genes suggests that CRV021 may be in-
volved in a conserved cellular function, possibly affecting as-
pects of viral host range.
CRV030 contains a J domain similar to those of the eukary-
otic family of 40-kDa heat shock proteins (Hsp40) and bacte-
rial DNA-J proteins. Notably, the only poxvirus homologue of
CRV030 MOCV is MC013L, a protein shown to interfere with
nuclear steroid receptor-mediated transcription (23). While
CRV030 is most similar to cellular proteins at the 60-amino-
acid amino-terminal J domain, including the highly conserved
HPD tripeptide, the carboxyl-terminal domain (positions 118
to 209) also shares similarity with the less conserved carboxyl-
terminal domain of Hsp40/DNA-J homologues (24% amino
acid identity with positions 250 to 346 of the human DnaJ-like
subfamily A protein; GenBank accession number AL162590).
CRV030 lacks both G/F-rich and putative zinc-finger domains
adjacent to the J domain found in many Hsp40/DNA-J homo-
logues; however, cellular J-domain proteins lacking these do-
mains are also common and potentially provide substrate spec-
ificity to Hsp70 recruitment (63).
J-domain proteins are cochaperones to the ubiquitous
Hsp70/DNA-K class of protein chaperones, proteins that me-
diate ATP-dependent protein folding and assembly. By recruit-
ing Hsp70 partners and accelerating the ATP hydrolysis cou-
pled with Hsp70 substrate binding and release, J-domain
proteins play important regulatory roles in the chaperone sys-
tem and affect multiple cellular processes (63). J-domain pro-
teins are also encoded by or affected by viruses. Three J-
domain proteins encoded by mimivirus have been speculated
to have chaperone functions and to interact with other mim-
ivirus proteins predicted to affect protein folding (98). Poly-
omavirus T antigens, proteins with multiple functions in viral
replication, virus-host cell interaction, and cellular transforma-
tion, contain amino-terminal J domains that possess Hsp40-
like activities and mediate interaction with cellular proteins,
including members of the retinoblastoma tumor suppressor
family and protein phosphatase 2A (63, 119). Cellular J-do-
main proteins have been shown to function in pestivirus
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polyprotein processing (100). Influenza virus infection results
in Hsp40/chaperone-mediated inhibition of P58IPK, a protein
which inhibits the interferon (IFN)-induced protein PKR, a
key regulator of cellular antiviral responses (79). CRV030L
may function as a virally encoded cochaperone, affecting chap-
erone-mediated processes in infected cells and mediating vi-
rus-cell interactions. Notably, MC013L has been shown to in-
teract in vitro directly with, and to inhibit the transcriptional
effects of, vitamin D and glucocorticoid nuclear receptors, pro-
teins that complex with cellular chaperones to affect their intra-
cellular concentration or ligand affinity (23, 74, 95). While the
MC013L J domain could conceivably interfere with normal ste-
roid receptor-chaperone complexes, mutation of the MC013L
HPD motif important for J-domain/Hsp70 interaction failed to
abrogate MC013L-mediated transcriptional inhibition (23). Al-
though the functional specifics of CRV030L relative to MC013L
are unclear, the lack of homologues in other poxviruses suggests
that their functions may affect mechanisms of virus-host interac-
tion common to, and perhaps of particular relevance for, these
two viruses.
CRV051 shares similarity with both bacterial transposon
resolvases and poxvirus homologues of VACV F16L, a protein
of unknown function. Transposon resolvases are proteins of
180 to 200 amino acids containing an amino-terminal catalytic
and dimerization domain, with a conserved S active-site resi-
due involved in transient covalent binding to DNA, and a
carboxyl-terminal helix-turn-helix DNA binding motif (113).
CRV051 shares similarity with the amino-terminal domain of
Staphylococcus site-specific serine recombinase-resolvases, in-
cluding the recognized site-specific recombinase motif and po-
tential active site residue at position 9 (PROSITE PS00397)
(Fig. 4), and it contains a portion of the carboxyl-terminal
region similar to recombinase helix-turn-helix regions (posi-
tion 170 to 188, data not shown). CRV051 also shares 24%
amino acid identify and a similar genomic location with
MC029L, the MOCV homologue of VACV F16L (Table 1).
Notably, poxvirus F16L homologues share very limited simi-
larity with recombinases; however, all contain amino-terminal
S residues which, conceivably, include a recombinase active
site (data not shown). This unexpected similarity of CRV051 to
both bacterial recombinases and poxvirus F16L homologues
suggests that F16L homologues may function as site-specific
recombinases.
Site-specific recombination of two DNA molecules results in
cointegration or excision of a DNA fragment, and it has been
hypothesized as a mechanism utilized during the replication of
linear genomes or for viral gene acquisition (66, 122). CRV
contains homologues of VACV H6R DNA topoisomerase I
(CRV106) and A22R Holliday junction resolvase (CRV145),
genes involved in the resolution of Holliday junction replica-
tive intermediates (telomere resolution) and in genomic re-
combination (41). It has been suggested that an additional, more
highly specialized viral enzyme(s) may be involved in telomere
resolution (66). Conceivably, CRV051 and other F16L homo-
logues may function in telomere resolution and/or gene acquisi-
tion. Notably, the absence of F16L homologues in avipoxviruses
FIG. 4. Multiple sequence alignment CRV051, MC029L (GenBank accession number U60315) and site-specific recombinase/integrase amino-
terminal regions. Highlighted are amino acids similar to CRV051. M. loti, Mesorhizobium loti (AP003017); B. subtilis, Bacillus subtilis (P17867);
M. mazei, Methanosarcina mazei (AE013525); Phi, bacteriophage phi-FC1 (AF124258); TP901, Lactococcus lactis bacteriophage TP901-1
(X85213); B. lichiniformis, Bacillus lichiniformis (AX930120); S. hominis, Staphylococus hominis (AB063171). Underlined letters are PROSITE
motif residues (PS00397). The putative active site residue S is indicated by boldface type. Numbers on the right indicate amino acid positions.
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suggests that this gene is highly divergent in avipoxviruses or,
alternatively, nonessential for viral replication.
Comparison of CRV with other ChPVs. Genome analysis
indicated that CRV is a highly divergent ChPV, containing
unique sequence features in both a ChPV-like central genomic
region and in completely novel terminal genomic regions. Be-
tween positions 33650 and 176791 (the region containing ho-
mologues of VACV F9L to A34R), CRV contained the 90
genes present in all known ChPVs, with the most conserved
genes involved in DNA replication and RNA biosynthesis
(Table 1) (48). Despite maintaining this minimal ChPV gene
complement, phylogenetic analyses of these proteins revealed
relatively large genetic distances between CRV and viruses of
other ChPV genera, indicating that CRV represents a new
poxvirus genus (Fig. 5).
Divergence between CRV and ChPVs in the central con-
served regions included notable differences in amino acid iden-
tity and length of encoded proteins. CRV proteins sharing a
low level of amino acid identity with ChPV homologues (less
than 34% to VACV homologues) included putative virion core
(CRV061, CRV079, and CRV110), IMV envelope (CRV103,
CRV135, and CRV140), IEV (CRV038), and EEV (CRV158)
proteins; glutaredoxin (CRV075); proteins of unknown func-
tion (CRV083 and CRV107); and, notably, several proteins
with putative functions in DNA replication or gene expression
(CRV051, CRV067, CRV105, CRV117, CRV143). CRV125
(70 amino acids) shares limited similarity with the amino-
terminal regions of the VACV A4L homologues, virion core
proteins that exhibit a relatively high degree of variability in
sequence identity and length among other ChPVs (148 to 421
amino acids).
A repetitive, proline-rich amino-terminal extension makes
CRV058 significantly larger (794 amino acids) than ChPV ho-
mologues (VACV E8R, 273 amino acids); however, an alter-
native start codon (M526) at genomic position 75345 would
yield a ChPV-like protein (270 amino acids). CRV105, the
homologue of VACV late transcription factor 4 (VLTF-4) is
smaller in size (123 amino acids) than ChPV homologues (170
to 228 amino acids), lacking an equivalent amino-terminal
domain. Similarly, CRV133, the homologue of VACV A12L
virion core protein, is smaller (140 amino acids) than its ChPV
homologues (161 to 260 amino acids), lacking a central domain
of low amino acid complexity (data not shown). These differ-
ences between CRV proteins and ChPV homologues exem-
plify the divergent nature of CRV and potentially reflect spe-
cific adaptation to the reptile host.
Novel gene arrangements at discrete loci within the central
genomic region also reflect the divergent nature of CRV.
ChPV-like gene colinearity is disrupted at several loci in the
CRV central genomic region, including the insertion of seven
GyrB-like ATPase domain genes (CRV084 to CRV090) at the
VACV L2R/L3L locus and two novel E2L/O1L-like genes
(CRV063 and CRV064) at the VACV O1L locus (Table 1). In
addition, CRV contains a single gene (CRV148) encoding a
homologue of the multiple A-type inclusion proteins present at
the homologous locus in other ChPVs, including MOCV,
parapoxviruses, and avipoxviruses (3, 30, 106).
Several features within or adjacent to the CRV central genomic
region are similar to other relatively divergent ChPVs, including
the avipoxviruses, parapoxviruses, and MOCV to which CRV
proteins were most similar in pairwise searches (Table 1).
CRV, like avipoxviruses, lacks homologues of the VACV E3L
interferon resistance protein and A33R EEV glycoprotein re-
quired for efficient actin tail-mediated cell-to-cell spread of
VACV (101), and CRV contains three VARV B22R-like ho-
mologues (CRV040, CRV041, CRV043) encoded at a locus
also containing a B22R-like gene in avipoxviruses (3). The
CRV genome shares certain features previously noted as com-
mon between MOCV and parapoxviruses, including a GC-
rich nucleotide composition and lack of genes present in most
other ChPVs (30). Notably, several CRV genes, although gen-
erally small in size and interspersed within the central region,
were similar to homologues found only in MOCV (CRV030,
CRV050, CRV091, CRV100, CRV108, CRV134, and CRV153),
FIG. 5. Phylogenetic analysis of CRV proteins. Eighty-three con-
served proteins between CRV036 and CRV147 were concatenated and
aligned with similar data sets from other ChPVs using MUSCLE. The
unrooted tree for 32,633 aligned characters was generated using max-
imum likelihood with WAG correction for multiple substitutions, four-
category discrete gamma model, estimation for invariant residues, and
100 bootstrap replicates as implemented in Phyml. Bootstrap values
greater than 70 are indicated at appropriate nodes, and dots indicate
values of 100. Homologous protein sequences from the following vi-
ruses and accession numbers were compared: bovine papular stoma-
titis virus (BPSV; GenBank accession number AY386265); canarypox
virus (CNPV; AY318871); ectromelia virus (ECTV; AF012825); deer-
pox virus W-848-83 (DPV83; AY689436); deerpox virus W-1170-84
(DPV84; AY689437); fowlpox virus (FWPV; AF198100); lumpy skin
disease virus (LSDV; AF325528); molluscum contagiosum virus (MOCV;
U60315); myxoma virus (MYXV; AF170726); orf virus (ORFV;
AY386264); rabbit (Shope) fibroma virus (SFV; AF170722); sheeppox
virus (SPPV; AY077833); swinepox virus (SWPV; AF410153); VACV,
M35027; Yaba-like disease virus (YLDV; AJ293568); Yaba monkey tu-
mor virus (YMTV; AY386371). Scale indicates estimated changes per
residue. Similar topologies were obtained using an alignment (22,055
characters) in which poorly aligned regions were trimmed with Gblocks;
using additional maximum likelihood analyses of the MUSCLE
alignment as implemented in PHYLIP, TREE-PUZZLE, IQPNNI,
and MRBAYES; using similar analyses on alignments generated with
with Dialign-T and Kalign; using Phyml results for supertree analysis
of multiple concatenated datasets and for supertree analysis of indi-
vidual proteins aligned with Kalign; or by conducting similar analyses
on a data set including only one virus per genus or major viral group
(10 taxa).
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suggesting a monophyletic relationship between the two vi-
ruses. Although neighbor joining and parsimony-based phylo-
genetic analyses of proteins from central conserved regions
indeed suggested CRV/MOCV monophyly (data not shown),
more robust maximum likelihood analyses indicated that CRV
and MOCV are not monophyletic relative to other ChPVs
(Fig. 5). Thus, despite the potentially synaptomorphic nature
of uniquely shared gene orthologues, the phylogenetic rele-
vance of other features shared between CRV and other ChPVs
is unclear, leaving CRV distinct within the subfamily Chordo-
poxvirinae.
Consistent with the relatively divergent nature of the CRV
central genomic region, proteins encoded by CRV genes lo-
cated within the left 33-kbp and right 13-kbp terminal genomic
regions are largely of unknown function and lacked similarity
to known poxvirus proteins (Table 1). CRV lacks ChPV gene
families and ChPV homologues involved in viral virulence,
host range, modulation of innate and adaptive immune re-
sponses, and modulation of apoptotic responses. CRV lacks
recognizable homologues of MC053L and MC054L interleukin
18 (IL-18) binding proteins, MOCV MC148R chemokine re-
ceptor antagonist, MC159L and MC160L vFLIP-like inhibitors
of apoptosis, and MC002L, MC161R, and MC162R SLAM/
CD150-like proteins (83, 111, 129). CRV also lacks homo-
logues of VACV C7L host range protein, K3L PKR/IFN re-
sponse antagonist, N1L, A46R, and A52R inhibitors of
intracellular signaling, A38L CD47-like protein, A39R sema-
phorin-like protein, A41L virulence protein, A44L -hydroxy-
steroid dehydrogenase, A45R superoxide dismutase, B5R
EEV protein, B7R virulence protein, B8R gamma interferon
receptor, B16R IL-1 receptor, and B19R alpha/beta interferon
receptor (6, 86, 112, 116). Absent are homologues of VACV
F1L and myxoma virus M004 and M011R antiapoptotic pro-
teins, myxoma virus -2,3-sialyltransferase, and ChPV chemo-
kine binding proteins and receptors, complement binding pro-
teins, and tumor necrosis factor receptor-like proteins (6, 17,
82, 127).
CRV is the first poxvirus of a reptile to be studied, and the
differences in the genome of CRV relative to other ChPVs,
especially the absence of recognizable poxvirus virulence and
host range genes, are notable. Although understanding of the
reptile immune system and its response to viral infection is
limited, it is known that reptiles produce immune cell popula-
tions morphologically similar to those found in avian and mam-
malian species, and they are thought to be capable of mounting
inflammatory, humoral, cellular, and cell-mediated immune
responses comparable to those present in higher vertebrates,
albeit affected by seasonal and thermoregulatory changes (13,
18). Conservation of vertebrate innate and adaptive immune
responses, including interferon, IL-1, tumor necrosis factor-
like receptor, complement, and Toll-like receptor-mediated
responses, that are interdicted by poxviruses of birds and mam-
mals suggest that such mechanisms are also likely manipulated
by CRV (13, 32, 62, 94). Thus, the complete lack of genes
predicted to involve manipulation of host immune responses in
CRV is striking. As is the case with other poxviruses encoding
novel proteins affecting host immune and apoptotic responses
(29, 47, 96, 127), it is likely that many of the novel genes
present in CRV encode proteins capable of affecting similar
host responses.
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ADDENDUM IN PROOF
Since the completion of the analyses presented here, similar
observations regarding F-box-like motifs in poxvirus ankyrin
repeat proteins have been reported (A. A. Mercer, S. B. Flem-
ing, and N. Ueda, Virus Genes 31:127–133, 2005).
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